Humana Inc. (NYSE:HUM) Position Trimmed by Valeo Financial Advisors LLC

Valeo Financial Advisors LLC reduced its holdings in Humana Inc. (NYSE:HUM) by 6.6% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 1,458 shares of the insurance provider’s stock after selling 103 shares during the quarter. Valeo Financial Advisors LLC’s holdings in Humana were worth $462,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Mendota Financial Group LLC lifted its position in Humana by 9.2% in the 2nd quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock valued at $119,000 after purchasing an additional 27 shares during the last quarter. Capital Advisors Ltd. LLC boosted its position in Humana by 17.0% during the 2nd quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock worth $80,000 after acquiring an additional 31 shares during the period. EP Wealth Advisors LLC lifted its position in Humana by 1.6% in the 4th quarter. EP Wealth Advisors LLC now owns 2,294 shares of the insurance provider’s stock worth $1,050,000 after buying an additional 37 shares in the last quarter. CarsonAllaria Wealth Management Ltd. raised its stake in shares of Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after purchasing an additional 39 shares in the last quarter. Finally, Harbour Investments Inc. lifted its stake in Humana by 10.5% in the second quarter. Harbour Investments Inc. now owns 432 shares of the insurance provider’s stock valued at $161,000 after acquiring an additional 41 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. TD Cowen lowered shares of Humana from a “buy” rating to a “hold” rating and dropped their price target for the company from $402.00 to $261.00 in a research report on Monday, October 7th. Jefferies Financial Group cut shares of Humana from a “buy” rating to a “hold” rating and dropped their price objective for the company from $519.00 to $253.00 in a research note on Monday, October 7th. Leerink Partnrs downgraded Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Truist Financial reduced their price target on shares of Humana from $400.00 to $260.00 and set a “hold” rating on the stock in a research report on Friday. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $395.00 target price on shares of Humana in a research note on Tuesday, October 1st. One investment analyst has rated the stock with a sell rating, nineteen have assigned a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $315.33.

Humana Stock Performance

Shares of Humana stock opened at $267.60 on Tuesday. The firm has a market cap of $32.25 billion, a price-to-earnings ratio of 16.66, a price-to-earnings-growth ratio of 1.91 and a beta of 0.50. Humana Inc. has a one year low of $213.31 and a one year high of $530.54. The stock’s 50-day moving average is $322.99 and its 200-day moving average is $339.86. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.66 and a quick ratio of 1.66.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.89 by $1.07. The company had revenue of $29.54 billion during the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 16.12% and a net margin of 1.53%. During the same quarter last year, the company earned $8.94 EPS. Humana’s revenue for the quarter was up 10.4% compared to the same quarter last year. Equities analysts predict that Humana Inc. will post 16.06 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.32%. The ex-dividend date of this dividend is Monday, September 30th. Humana’s dividend payout ratio (DPR) is presently 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.